AbbVie Inc.ABBVNYSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+10.0%
5Y CAGR+9.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.0%/yr
vs +4.8%/yr prior
5Y CAGR
+9.5%/yr
Consistent
Acceleration
+5.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $29.98B | -1.0% |
| 2024 | $30.29B | +43.3% |
| 2023 | $21.15B | -6.1% |
| 2022 | $22.52B | +8.1% |
| 2021 | $20.83B | +9.3% |
| 2020 | $19.05B | +48.3% |
| 2019 | $12.84B | -31.1% |
| 2018 | $18.65B | +60.4% |
| 2017 | $11.63B | +11.1% |
| 2016 | $10.47B | - |